MedTrace Logo

A Study to Investigate the Efficacy of AlphaWave® L-Theanine on Stress

NCT04706494 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-01-12

No results posted yet for this study

Summary

AlphaWave® L-theanine will be compared against placebo to evaluate how the investigational study product effects on salivary cortisol, EEG readings, blood pressure, and heart rate in a moderately stressed and otherwise healthy adult population. It is hypothesized that participants taking the AlphaWave® L-theanine will have reduced stress levels as assessed by the parameters stated. Participants will be consuming the investigational study product or placebo in the clinic only.

Conditions

  • Stress

Interventions

DIETARY_SUPPLEMENT

AlphaWave® LTheanine

200 mg of AlphaWave® LTheanine

DIETARY_SUPPLEMENT

Placebo

microcrystalline cellulose

Sponsors & Collaborators

  • Ethical Naturals, Inc.

    lead OTHER

Principal Investigators

  • Mal Evans, PhD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-02
Primary Completion
2020-09-25
Completion
2020-09-25

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04706494 on ClinicalTrials.gov